Healthcare Index is up 60% year to date. While other sectors especially retail facing ones, whose performance depended on footfalls underwent tremendous stress in the period immediately following lockdown, healthcare demonstrated solid remarkable resilience. "The essential nature of the industry came to the fore, as frantic pre-buying of chronic drugs (diabetes, cardiac, blood pressure medications) drove growth in March," says Bhavesh Gandhi, Lead Analyst – Institutional Equities, Yes Securities.Will the outperformance in pharma sector continue in 2021?
Analysts at Yes Securities expect COVID-led drug tailwinds and pre-stocking to have ended in H1 CY20. "2021 could bring the focus on vaccine manufacturing and distribution capabilities,.